Synthesis of New 8-Formyl-4-methyl-7-hydroxy Coumarin Derivatives
461
(C-2', C-6'), 126.5 (C-3', C-5'), 126 (C-1'), 125.2 (C-5),
118.2 (C-7), 115 (C, -CN), 114.5 (C-6), 112.5 (C-3), 112
(C-9), 103 (C-CN), 43.0 (C, -CH2), 19.5 (C, -CH3); MS:
m/z(M++1) 361.9; Anal. Calcd for C21H16N2O4: C, 69.99;
H, 4.48; N, 7.77; O, 17.76. Found C, 69.89; H, 4.44; N,
7.80; O, 17.66.
8-yl) N,N-dimethylacrylamide (7g)
IR (KBr, cm-1): 3442 (-OH), (-CN), 1742 (-CO), 1644
(cyclic -CO), 1594 (-C=C); 1H NMR (DMSO-d6): 11.8 (s,
-OH), 8.3 (s, H, -ethylene), 6.2-7.5 (m, 3H coumarin ring),
3.02 (d, 6H, -N(CH3)2), 2.43 (s, 3H, -CH3); 13C NMR
(DMSO-d6): δ 160.5 (-CO), 159.7 (C-2), 155 (C-7), 153
(C, exocyclic ethylene), 152.5 (C-5), 146 (C-10), 125.2
(C-3), 118.2 (C-8), 115 (-CN), 114.0 (C-6), 112.5 (C-3),
112.0 (C-5), 107 (C, ethylene), 36.6 (2C, -N(CH3)2), 19.5
(C, -CH3); MS: m/z(M++1): 300.0; Anal. Calcd for
C16H14N2O4: C, 64.42; H, 4.73; N, 9.39; O, 21.45. Found;
C, 64.24; H, 4.69; N, 9.55; O, 21.59.
(E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-
2-(piperidine-1-carbonyl) acrylonitrile (7d)
IR (KBr, cm-1): 3442 (-OH), 2240.3 (-CN), 1742 (-CO),
1644 (cyclic -CO), 1594 (-C=C); 1H NMR (DMSO-d6): δ
11.79 (s, -OH), 8.32 (s, H, exocyclic CH=C), 6.2-7.55 (m,
3H, coumarinring), 3.7 (m, 4H, piperidine), 2.5 (s, 3H, CH3),
1.6 (m, 2H piperidine), 1.53 (m, 4H, piperidine); 13C NMR
(DMSO-d6): δ 170.5 (CO), 160 (C-2), 155 (C-7), 153 (C,
ethylene), 152.7 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-
8), 115 (CN), 114.0 (C-6), 112.5 (C-3), 112.0 (C-9), 106
(C, ethylene), 47.0 (2C, piperidine), 25.0 (2C, piperidine), 24.1
(C, piperidine), 19.5 (C, -CH3); MS: m/z (M++1) 339.3;
Anal. Calcd for C19H18N2O4: C, 67.44; H, 5.36; N, 8.28;
O, 18.91. Found; C, 67.40; H, 5.39; N, 8.31; O, 18.20.
(E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-
2-(pyrrolidine-1-carbonyl)acrylo nitrile (7e)
(E)-2-cyanoN,N-diethyl-3-(7-hydroxy-4-methyl-2-oxo-
2H-chromen-8-yl) acrylamide (7h)
IR (KBr, cm-1): 3442 (-OH), 2254 (-CN), 1742 (-CO),
1644 (cyclic -CO), 1594 (-C=C); 1H NMR(CDCl3): δ 11.8
(s, -OH), 8.3 (s, H, ethylene), 6.24-7.55 (m, 3H coumarin
ring), 3.72 (q, 4H, -H2C-N-CH2), 2.4 (s, 3H, -CH3), 1.34
(t, 6H, - (CH3)2); 13C NMR (CDCl3): δ 160.5 (CO), 159.7
(C-2), 155 (C-7), 153 (C-4), 146 (C-10), 125.2 (C-5),
118.2 (C-8), 115 (CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-
9), 106 (C, ethylene), 40.8 (q, 2C, -CH2), 19.5 (C, -CH3),
12.5 (t, 2C, -(CH3)2); MS: m/z(M++1): 327.5; Anal. Calcd
for C18H18N2O4: C, 66.25; H, 5.56; N, 8.58; O, 19.61.
Found; C, 66.30; H, 5.64; N, 8.65; O, 19.16.
IR (KBr, cm-1): 3442 (-OH), 2246 (-CN), 1742 (-CO),
1644 (cyclic -CO), 1594 (-C=C); 1H NMR (DMSO-d6): δ
11.8 (s, -OH), 8.35 (s, H, exocyclic CH=C), 6.23-7.5 (3H,
coumarin), 3.25 (t, 4H, pyrrolidine), 2.43 (s, 3H, -CH3),
1.72 (t, 4H, pyrrolidine); 13C NMR (DMSO-d6): δ170.7 (-CO),
160, (C-2), 155 (C-7), 153 (C, expcyclic ethylene), 146
(C-10), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.0 (C-6),
112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 45.7 (2C, pyrro-
lidine), 25.0 (2C, pyrrolidine), 19.5 (C, -CH3); MS: m/
z(M++1) 325.3; Anal. Calcd for C18H16N2O5: C, 66.66; H,
4.97; N, 8.64; O, 19.73. Found; C, 66.76; H, 5.02; N, 8.54;
O, 19.80.
(E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-
8-yl) N,N-diisopropylacrylamide (7i)
IR (KBr, cm-1): 3442 (-OH), 2244 (-CN), 1742 (-CO),
1644 (cyclic -CO), 1594 (-C=C); 1H NMR (CDCl3): 11.8
(s, -OH), 8.35 (s, exocyclic ethylene), 6.23-7.55 (m, 3H,
coumarin ring), 4.0 (m, 2H, -CH-), 2.45 (s, 3H, -CH3),
1.27 (d, 12H, 4Me of isopropyl): 13C NMR (CDCl3): δ
160.5 (CO), 159.7 (C-2), 155 (C-7), 153 (C, exocyclic
ethylene), 152.7 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-
8), 115 (CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 107
(C, ethylene), 47.0 (2C, -CH), 19.5 (C - CH3), 21.5 (t, 4C,
-4CH3 of isopropyl); MS: m/z(M++1): 355.4; Anal. Calcd
for C20H22N2O4: C, 67.78; H, 6.26; N, 7.90; O, 18.06.
Found; C, 67.87; H, 6.30; N, 8.01; O, 18.14.
(E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-
8-yl) N-methylacrylamide (7f)
IR (KBr, cm-1): 3442 (-OH), 3225 (-NH), 2248 (-CN),
1
1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); H NMR
(DMSO-d6): 11.8 (s, OH), 8.4 (s, H, exocyclic ethylene),
8.1 (m, -NH), 6.22-7.5 (m, 3H, coumarin ring), 2.72 (d,
3H, -HN-CH3), 2.43 (s, 3H, -CH3); 13C NMR (DMSO-d6):
δ 160.5 (CO), 159.7 (C-2), 155 (C-7), 153.8 (C, exocyclic
ethylene), 153 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-
8), 115 (CN), 114.5 (C-6), 112.5 (C-3), 112.0 (C-9), 104
(C, ethylene), 25.5 (-NH-CH3), 19.5 (C, -CH3); MS: m/
z(M++1): 285.3; Anal. Calcd for C15H12N2O4: C, 63.38;
H, 4.25; N, 9.85; O, 22.51. Found; C, 63.80; H, 4.19; N,
9.65; O, 22.39.
(E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-
2-(1H-imidazole-1-carbonyl)acrylo nitrile (7j)
IR (KBr, cm-1): 3442 (-OH), 2254 (-CN), 1742 (-CO),
1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C, -C=N); 1H
NMR (DMSO-d6): 11.8 (s, OH), 8.35 (s, H exocyclic
ethylene), 6.23-7.55 (m, 3H coumarin ring), 8.14 (s, H,
imidazole), 7.4 (d, H, imidazole), 7.14 (d, H, imidazole),
2.45 (s, 3H, -CH3); 13C NMR(DMSO-d6): δ 189.7 (C, -CO),
162 (C, exocyclic ethylene), 160.5 (C-2), 155 (C-7), 153
(C-4), 136.7 (C, imidazole), 130.0 (C, imidazole), 146 (C-
(E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-
2012, Vol. 56, No. 4